National Drug & Alcohol Research Centre Blog

FEBRUARY 24, 2022

Olivia Price It has been one year since the COVID-19 vaccine rollout commenced in Australia, and while vaccination rates initially lagged behind other countries, over 95% of Australians aged 12 years and older are now fully vaccinated. We tend to consider the remaining unvaccinated people a homogenous ‘anti-vax’ group.

Vaccine 52

Vaccine Drugs Disease Pharmaceuticals 52

Eye on FDA

JULY 19, 2021

It has been a regular feature of the blog to give a read on what FDA has been talking about, at least through the form of press releases. It is not always an easy task because the nature of FDA’s practice in this respect has evolved over time. Apologies for the misfire, but hopefully we are working more smoothly now.

FDA 93

FDA Vaccine Treatment Drugs 93

Crown Bioscience

JUNE 28, 2022

In this blog post we explore how immuno-oncology can draw from precision medicine to create more personalized cancer therapies to enhance their safety and efficacy. Precision medicine and immunotherapy continue to top the list as two of the hottest areas in cancer research.

Therapies 52

Therapies Vaccine Science Research 52

Crown Bioscience

JULY 10, 2022

In this blog post we explore how immuno-oncology can draw from precision medicine to create more personalized cancer therapies to enhance their safety and efficacy. Precision medicine and immunotherapy continue to top the list as two of the hottest areas in cancer research.

Therapies 52

Therapies Vaccine Science Research 52

Plenge Gen

MAY 28, 2021

My response was programmable therapeutics, a topic which I have blogged about in the past. In this blog I define programmable therapeutics and provide a few recent examples (severe combined immune deficiency and mRNA vaccines).

Vaccine 52

Vaccine Drug Development Trials Drugs 52

PerkinElmer

MAY 7, 2021

There’s a constant hunt for new, effective vaccines that could replace current, commonly used ones that viruses have developed a resistance to-and plate readers are commonly used to study viral mutations in vaccine research. The post Hey…Walkaway on the Automated Side first appeared on PerkinElmer Blog.

Vaccine 52

Vaccine DNA Compliance Virus 52

National Institute on Drug Abuse: Nora's Blog

FEBRUARY 1, 2024

50 years after founding, NIDA urges following science to move beyond stigma area Thu, 02/01/2024 - 11:20 Nora's Blog February 1, 2024 Image NIDA Image In 2024, NIDA celebrates its 50th anniversary.

Science 122

Science FDA Approval Treatment Research 122

National Institute on Drug Abuse: Nora's Blog

AUGUST 14, 2023

Innovative projects answer NIDA’s challenge to implement substance use prevention in primary care astewart Mon, 08/14/2023 - 10:04 Nora's Blog August 22, 2023 Image ©Getty Images/ Maskot With nearly 110,000 people dying from drug overdoses last year, the crisis has not abated.

Vaccine 68

Vaccine Nurses Treatment Drugs 68

Eye on FDA

FEBRUARY 22, 2022

In a recent blog posting, I looked back at the profile of FDA press releases over the period 2013-2021 (See What They Said 2021 – An Overview of FDA Press Statements ). There may be some complacence – a feeling that the ubiquitous Omicron has fostered a feeling of inevitability about exposure and eventual infection.

FDA 75

FDA Vaccine Science 75

PerkinElmer

JULY 12, 2022

Earlier this year, the World Health Organization (WHO) announced that over one million African children had received one or more doses of the world’s first malaria vaccine, RTS,S/AS01 (RTS,S). Tedros Adhanom Ghebreyesus said: “This vaccine is not just a scientific breakthrough, it’s life-changing for families across Africa.

Vaccine 52

Vaccine Drugs Treatment Disease 52

EG Life Sciences

FEBRUARY 15, 2023

Together, top vaccine development companies can join efforts, being transparent with one another to finally stop the spread of the virus around the world. Thanks for connecting with us, and we invite you to continue checking in to the EG Life Sciences Content Library for additional interesting blogs, white papers, and more.

Drug Development 52

Drug Development FDA Approval Drugs Virus 52

DS in Pharmatics

APRIL 4, 2025

The Center for Biologics Evaluation and Research (CBER) plays a critical role in overseeing the approval of innovative biologic products, including gene therapies, cell-based treatments, and vaccines.

Vaccine 52

Vaccine Therapies Treatment Production 52

NIH Director's Blog: Drug Development

DECEMBER 15, 2020

Indeed, it shows that no matter your current experience with COVID-19, there are opportunities to get involved to develop vaccines and medicines that will help everyone. This registry is creating a list of potential volunteers willing to take part in ongoing or future NIH clinical trials focused on preventing COVID-19—like vaccines.

Clinical Trials 52

Clinical Trials Vaccine Trials Immune Response 52

PerkinElmer

JUNE 14, 2021

The speed at which researchers developed effective vaccines to prevent the spread of COVID-19 required unprecedented international cooperation on a scale never seen before. Rollout of approved vaccines is underway in many countries across the globe, giving people hope that the end to the pandemic is finally in sight.

Virus 52

Virus RNA Vaccine Treatment 52

FDA Law Blog: Biosimilars

JUNE 2, 2023

Best Price Stacking We previously blogged about the 4 th Circuit Court of Appeals decision in United States Ex Rel. Vaccine”: Because vaccines are excluded from the MDRP, CMS proposes to define them solely for purposes of the MDRP. Sheldon, v.

Drugs 59

Drugs Regulations Vaccine Government 59

PerkinElmer

FEBRUARY 28, 2022

This collaborative effort resulted in the accelerated development and authorization of several novel COVID-19 vaccines. While vaccines have proved successful, there are currently no effective therapeutics available to treat SARS-CoV-2 infection, with the exception of the broad-spectrum antiviral Veklury (remdesivir). 2021;102(4).

Virus 52

Virus Vaccine Clinical Trials Treatment 52

Advarra

JULY 6, 2023

This blog is intended to provide guidance and clarity on reporting such unexpected events. When unexpected events occur during the conduct of a clinical trial, research personnel may wonder if the event is reportable, and if so, to whom. Who Should I Report Unexpected Events to? Which Incidents Should I Report?

Engineering 52

Engineering Clinical Trials Research Therapies 52

PerkinElmer

AUGUST 13, 2020

The virus, which can cause a severe form of pneumonia and lead to acute respiratory distress, currently has no FDA-approved targeted therapeutic or vaccine. Sources [link] [link] The post Use of Ultra-High-Throughput Screening in Discovery of COVID-19 Virus Structure first appeared on PerkinElmer Blog.

Virus 52

Virus Cell Based Assays FDA Approval Clinical Trials 52

PerkinElmer

AUGUST 18, 2020

This is especially applicable to labs involved in the development of highly sought-after viral therapeutics and vaccines. Viral plaque assays are standard tools in the development of antiviral drugs and vaccines, but this method is traditionally time-intensive and error prone due to manual counting. Sources Zhang et al.

Virus 52

Virus Vaccine RNA DNA 52

PerkinElmer

JUNE 23, 2020

The pharmaceutical industry is no exception with clinical trials are underway to develop a vaccine and identify potential therapeutics. The post Pharma’s Adaptive Agility and COVID-19 first appeared on PerkinElmer Blog.

Clinical Trials 52

Clinical Trials Pharmaceuticals Trials Virus 52

PerkinElmer

JANUARY 21, 2021

AlphaLISA assay technology can be used in small molecule discovery but can also be applied to large molecule discovery, including biologics, vaccines and cell-based therapies. The post Repurpose, Reuse, Rediscover Drugs for COVID-19 Treatments first appeared on PerkinElmer Blog.

Treatment 52

Treatment Small Molecule Drugs Virus 52

The Pharma Data

MAY 12, 2021

This posting has given me some good ideas for my new blog. as well as with the layout on your blog. Anyway keep up the excellent quality writing, it’s rare to see a nice blog like this one these days. I blog frequently and I seriously appreciate your content. Great, thanks for sharing this blog article.Much thanks again.

Production 52

Production Vaccine Engineering International 52

Molecule Blog

APRIL 26, 2020

The hunt for cures and vaccines for COVID-19 is forcing scientists, governments and the public at large to rethink our current biopharma innovation models. Over the past months, we saw existing drugs being fast-tracked and research teams from across the globe joining forces to create novel vaccines at breakneck speed.

Vaccine 52

Vaccine Government Laboratories Treatment 52

SugarCone Biotech

MAY 28, 2019

Whether its vaccines preventing SARS-Cov2 infection, or greenhouse gases causing Climate Change, we find it hard to convince people that our hypotheses are supported by the available evidence. So, another hypothesis is: PFIZER/BIONTECH’S VACCINE BNT162B2 PREVENTS SARS-COV2 VIRUS INFECTION. First, it’s not new. So that’s good!

Vaccine 52

Vaccine Clinical Trials Virus Science 52

NIH Director's Blog: Drug Development

JUNE 30, 2020

These findings help not only to understand the immune response to COVID-19, they are also critical for vaccine design, revealing what a strong neutralizing antibody for SARS-CoV-2 should look like to help the immune system win. Reference : [1] Convergent antibody responses to SARS-CoV-2 in convalescent individuals. 2020 Jun 18.

Immune Response 52

Immune Response Virus Vaccine Research 52

FDA Law Blog: Drug Discovery

JUNE 12, 2024

We are looking forward to seeing the START pilot program chart a path for a broader application of this more enhanced communication approach and FDA’s continued collaboration to facilitate development of new drugs for rare diseases, as we know there are many programs that would benefit from this approach, not just those included in the pilot.

Disease 59

Disease Clinical Trials Clinical Development FDA 59

DS in Pharmatics

MARCH 22, 2023

The Biomedical Advanced Research and Development Authority (BARDA) is) probably best known for its role in Operation Warp Speed and subsequent efforts to accelerate the manufacturing of COVID-19 vaccines. BARDA, formed in 2006, anticipated threats such as the COVID-19 pandemic.

Production 52

Production Vaccine Research 52

Advarra

JUNE 13, 2023

Research in gene therapies and genetically engineered drugs and vaccines are growing exponentially, and will only continue to become more popular. Diving deeper, this blog explores how research sites are focusing on their institutional biosafety committee (IBC) programs as part of overall study activation time.

Therapies 52

Therapies Research Clinical Trials Trials 52

PerkinElmer

JUNE 3, 2022

1 Although effective COVID-19 vaccines have been developed, variants of SARS-CoV-2 have already emerged for which vaccines are less effective, and many people remain unvaccinated due to certain medical conditions, personal choice, or global access challenges. Journal of the American Chemical Society. 2022;144(7):2905-2920.

Fragment Screening 52

Fragment Screening Clinical Trials Vaccine Pharmacokinetics 52

Perficient: Drug Development

JULY 18, 2024

Welcome to the fourth installment of our Universal Design and Health System blog series. By offering a range of services, such as vaccination clinics, wellness programs, and educational workshops, these facilities support the health and well-being of entire communities.

Disease 52

Disease Vaccine Treatment Therapies 52

NIH Director's Blog: Drug Development

FEBRUARY 16, 2021

A leader in this critical effort is NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV ) initiative, a public-private partnership involving 20 biopharmaceutical companies, academic experts, and multiple federal agencies. Vaccines Working Group : Accelerates the evaluation of vaccine candidates.

Clinical Trials 52

Clinical Trials Trials Hospitals Vaccine 52

Translation

OCTOBER 26, 2022

Ginkgo has also supported a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. The post Meet our newest partners: Gingko Bioworks, Amcor, Altium, and one.five appeared first on Translation | Halo Blog.

Packaging 52

Packaging Production Engineering Pharmaceuticals 52

PerkinElmer

APRIL 21, 2020

There are currently no targeted therapeutics for its treatment, nor is there an existing vaccine. Sources [link] [link] [link] [link] The post High Content Imaging Solutions Aid in Screen for Zika Virus Inhibitors first appeared on PerkinElmer Blog.

Virus 52

Virus FDA Approval Laboratories Vaccine 52

PerkinElmer

JULY 13, 2020

Studying viral mutation is critical for designing effective vaccines, antiviral drugs and diagnostic assays. The post Genomic Sequencing Paves the Way for Better Antiviral Treatments first appeared on PerkinElmer Blog. Click here for more information on quantifying DNA using the VICTOR Nivo.

Treatment 52

Treatment Virus DNA RNA 52

LifeSciVC

JANUARY 25, 2024

By Arthur Tzianabos, CEO of Lifordi Immunotherapeutics, as part of the From the Trenches feature of LifeSciVC Well, this is a first… while I have read and enjoyed the the LifeSci VC blog for years, being asked to contribute for the first time yielded a ‘holy crap’ moment in the ‘be careful what you wish for’ category.

Science 72

Science Clinical Trials Trials Medical Schools 72

PerkinElmer

JANUARY 25, 2023

As a result, vaccine developers are eager to incorporate T cell testing into their clinical trials not only for future COVID-19 vaccines, but those to help prevent and defend against other infectious diseases too. Click the button below to view other blog posts authored by technical experts on laboratory best practices.

Science 52

Science Laboratories Immune Response Disease 52

Codon

MAY 30, 2023

Read *An engineered influenza virus to deliver antigens for lung cancer vaccination. Read Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia. Read A non-transmissible live attenuated SARS-CoV-2 vaccine. million children have received this vaccine so far, and the rollout is far from simple.

DNA 52

DNA RNA Engineering Vaccine 52